M2VA Pain Care Pathway
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorYale University
About this trial
The goal of this 2-cohort, cluster randomized, type 2 hybrid trial is to test the effectiveness, cost-effectiveness and patient-level effects of an implementation facilitation strategy in helping M2VA case managers adopt a Military2VA Pain Care Pathway (M2VAPCP) intervention.
The main questions it aims to answer are:
Will adding implementation facilitation to training-as-usual for M2VAPCP result in a higher proportion of Veterans who receive M2VAPCP compared to training-as-usual alone? Will adding implementation facilitation to training-as-usual for M2VAPCP result in better adherence to the M2VAPCP protocol compared to training-as-usual alone? Will implementation facilitation improve Veterans' clinical outcomes (pain, risky substance use) and increase the number of non-pharmacological pain treatments used compared to training-as-usual alone?
Eligibility criteria
Qualifiers
Study enrollment is within one year of ending military service
Has filed a service-connection claim for an MSD (back, neck, knee, or shoulder condition)
Lives within the catchment area of a participating site
Disqualifiers
Reports being unable to complete planned study assessments because of anticipated incapacity, incarceration, or other reason
Does not have a landline or cell phone to complete study assessments
Is unable to provide informed consent
Still on active duty
Trial design
Treatments tested in this trial
- M2VA Pain Care Pathway (M2VAPCP)
- Implementation Facilitation
Treatment groups
1,800 Participants
are divided into 2 treatment groupsSponsors and collaborators
Yale University
Lead sponsor
National Center for Complementary and Integrative Health (NCCIH)
Collaborator
VA Connecticut Healthcare System
Collaborator
Source ClinicalTrials.gov